 |
 |
|
Home |
Current Issue |
Past Issues |
In the Clinic |
ACP Journal Club |
CME |
Collections |
Audio/Video |
Mobile |
Subscribe |
Tools |
Help |
ACP Online
|
1 June 1997 | Volume 126 Issue 11 | Pages 849-857
Background: Transjugular intrahepatic portosystemic shunts (TIPS) have widened the use of portal decompression as therapy for variceal hemorrhage. However, no controlled studies have examined the efficacy of TIPS compared with that of other treatments.
Objective: To compare the efficacy and safety of TIPS with those of endoscopic sclerotherapy for the prevention of recurrent variceal hemorrhage.
Design: Randomized, controlled trial.
Setting: Tertiary-care academic medical center.
Patients: 100 patients with cirrhosis were evaluated a mean of approximately 10 days after an episode of acute variceal bleeding; 20 patients were excluded because of portal venous thrombosis (n = 6), hepatoma (n = 3), florid alcoholic hepatitis (n = 6), and refusal to give consent (n = 5).
Interventions: TIPS (n = 41) or sclerotherapy (n = 39). The latter was performed by freehand injections of 5% Na morrhuate at 2- to 3-week intervals. Recurrent variceal hemorrhage was managed by sclerotherapy followed by angiographic assessment of TIPS and dilatation of the stents (TIPS group) or crossover to TIPS (sclerotherapy group).
Measurements: Rebleeding and survival were the primary end points. Complications and rates of rehospitalization were secondary end points.
Results: During a mean follow-up of approximately 1000 days, recurrent gastrointestinal bleeding resulted from variceal hemorrhage (9 patients in the TIPS group and 8 in the sclerotherapy group), portal gastropathy (1 patient in each group), and gastric lipoma (0 and 1 patients, respectively). A higher mortality rate was seen with TIPS (P = 0.03). Death resulted from variceal bleeding (5 patients in the TIPS group and 3 in the sclerotherapy group), sepsis (3 and 2 patients, respectively), liver failure (2 patients in each group), hepatoma (1 and 0 patients, respectively), and hemoperitoneum (1 and 0 patients, respectively). Encephalopathy was the most common complication in the TIPS group (n = 12), and pain developing after sclerotherapy was the most common in the sclerotherapy group (n = 10). The two groups had similar rates of rehospitalization.
Conclusions: Endoscopic sclerotherapy and TIPS are equivalent with respect to rebleeding developing over the long term. However, sclerotherapy may be superior to TIPS with respect to survival.
Author and Article Information
From Medical College of Virginia, Richmond, Virginia
ARTICLE
Transjugular Intrahepatic Portosystemic Shunts Compared with Endoscopic Sclerotherapy for the Prevention of Recurrent Variceal Hemorrhage
A Randomized, Controlled Trial
Acknowledgment: The authors thank the nursing staff of the Clinical Research Center for its dedicated efforts.
Grant Support: In part by an award from the National Institutes of Health to the Clinical Research Center at the Medical College of Virginia (RR-00065) and an award from the American College of Gastroenterology.
Requests for Reprints: Arun J. Sanyal, MD, Medical College of Virginia, MCV Station 980711, 11th and Marshall Streets, Richmond, VA 23298-0711.
Current Author Addresses: Dr. Sanyal: Medical College of Virginia, MCV Station 980711, 11th and Marshall Streets, Richmond, VA 23298-0711.
Related articles in Annals:
This article has been cited by other articles:
|
|
 |
|
  C. Vignali, I. Bargellini, M. Grosso, G. Passalacqua, F. Maglione, F. Pedrazzini, P. Filauri, R. Niola, R. Cioni, and P. Petruzzi TIPS with Expanded Polytetrafluoroethylene-Covered Stent: Results of an Italian Multicenter Study Am. J. Roentgenol., August 1, 2005; 185(2): 472 - 480. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Rossi, F. M. Salvatori, F. Fanelli, M. Bezzi, M. Rossi, G. Marcelli, D. Pepino, O. Riggio, and R. Passariello Polytetrafluoroethylene-covered Nitinol Stent-Graft for Transjugular Intrahepatic Portosystemic Shunt Creation: 3-year Experience Radiology, June 1, 2004; 231(3): 820 - 830. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D Tripathi, H F Lui, A Helmy, K Dabos, E Forrest, A J Stanley, R Jalan, D N Redhead, and P C Hayes Randomised controlled trial of long term portographic follow up versus variceal band ligation following transjugular intrahepatic portosystemic stent shunt for preventing oesophageal variceal rebleeding Gut, March 1, 2004; 53(3): 431 - 437. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Z. W. Zhuang, G. J. Teng, R. F. Jeffery, J. M. Gemery, B. J. d'Othee, and M. A. Bettmann Long-Term Results and Quality of Life in Patients Treated with Transjugular Intrahepatic Portosystemic Shunts Am. J. Roentgenol., December 1, 2002; 179(6): 1597 - 1603. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. I. Sharara and D. C. Rockey Gastroesophageal Variceal Hemorrhage N. Engl. J. Med., August 30, 2001; 345(9): 669 - 681. [Full Text] [PDF]
|
|
|
|
|
|
G Pomier-Layrargues, J-P Villeneuve, M Deschenes, B Bui, P Perreault, D Fenyves, B Willems, D Marleau, M Bilodeau, M Lafortune, et al. Transjugular intrahepatic portosystemic shunt (TIPS) versus endoscopic variceal ligation in the prevention of variceal rebleeding in patients with cirrhosis: a randomised trial Gut, March 1, 2001; 48(3): 390 - 396. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R Jalan and P C Hayes UK guidelines on the management of variceal haemorrhage in cirrhotic patients Gut, June 1, 2000; 46(90003): iii1 - 15. [Full Text] [PDF]
|
|
|
|
|
|
R JALAN, H F LUI, D N REDHEAD, and P C HAYES TIPSS 10 years on Gut, April 1, 2000; 46(4): 578 - 581. [Full Text] [PDF]
|
|
|
|
|
|
Z. J. Haskal Improved Patency of Transjugular Intrahepatic Portosystemic Shunts in Humans: Creation and Revision with PTFE Stent-Grafts Radiology, December 1, 1999; 213(3): 759 - 766. [Abstract] [Full Text]
|
|
|
|
|
|
A. Luca, G. D'Amico, R. La Galla, M. Midiri, A. Morabito, and L. Pagliaro TIPS for Prevention of Recurrent Bleeding in Patients with Cirrhosis: Meta-analysis of Randomized Clinical Trials Radiology, August 1, 1999; 212(2): 411 - 421. [Abstract] [Full Text]
|
|
|
|
 |
|
 R. L. Jenkins, R. Gedaly, J. J. Pomposelli, E. A. Pomfret, F. Gordon, and W. D. Lewis Distal Splenorenal Shunt: Role, Indications, and Utility in the Era of Liver Transplantation Arch Surg, April 1, 1999; 134(4): 416 - 420. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 ""TIPS"" OR SCLEROTHERAPY FOR ESOPHAGEAL VARICES? Journal Watch (General), June 17, 1997; 1997(617): 2 - 2. [Full Text]
|
|
|
|
|
|
M. Cejna, M. Peck-Radosavljevic, S. A. Thurnher, K. Hittmair, M. Schoder, and J. Lammer Creation of Transjugular Intrahepatic Portosystemic Shunts with Stent-Grafts: Initial Experiences with a Polytetrafluoroethylene-covered Nitinol Endoprosthesis Radiology, November 1, 2001; 221(2): 437 - 446. [Abstract] [Full Text] [PDF]
|
|
Article
